← Back to Clinical Trials
Recruiting NCT07460804

NCT07460804 FOA on Sit to Stand in Individuals Post Chronic Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07460804
Status Recruiting
Phase
Sponsor Western Carolina University
Condition Stroke
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2025-03-26
Primary Completion 2027-05-16

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Focus of Attention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2025-03-26 with a primary completion date of 2027-05-16.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to fill some gaps in the literature by examining the effects of focus of attention on motor learning and motor performance of sit to stand in individuals post chronic stroke. This study will investigate whether an internal or external focus of attention can lead to improved use of the affected lower extremity during the sit to stand transition, while maintaining an upright trunk position. More specifically, the study has two purposes. The first is to determine whether an external or internal focus of attention would lead to better motor learning of sit to stand. This is measured by retention testing and transfer of the task to changes in affected lower extremity weight bearing during gait. The second purpose of this study is to investigate whether an internal or external focus of attention affects the performance of sit to stands during training.

Eligibility Criteria

Inclusion Criteria: * Stroke \>6 months * Mild to moderate stroke (NIHSS scores 0-15) Exclusion Criteria: * Unable to perform sit to stand from a standard height 20" chair without physical assistance * Unable to walk 20 feet with or without an assistive device at a contact guard to independent level * Individuals with severe cognitive impairment (\<10/30 on the Montreal Cognitive assessment) * Contraversive pushing (\> 1 on the Scale for Contraversive Pushing) * Neglect as evidenced by \<44/54 on the star cancellation test * Any orthopedic conditions that impact their ability to transition from sit to stand will be excluded from the study. * Any other neurologic conditions that impact their ability to transition from sit to stand will be excluded from the study. * Minors, prisoners, pregnant women will also be excluded. * Non English speaking individuals due to lack of interpretation resources.

Contact & Investigator

Central Contact

Ashley Watamura, PT, DPT, PhD

✉ awhyatt@email.wcu.edu

📞 717-682-9710

Frequently Asked Questions

Who can join the NCT07460804 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07460804 currently recruiting?

Yes, NCT07460804 is actively recruiting participants. Contact the research team at awhyatt@email.wcu.edu for enrollment information.

Where is the NCT07460804 trial being conducted?

This trial is being conducted at Cullowhee, United States.

Who is sponsoring the NCT07460804 clinical trial?

NCT07460804 is sponsored by Western Carolina University. The trial plans to enroll 20 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology